NME THERAPEUTICS, EMPOWERING NMES TO FIGHT ENEMIES OF HUMAN HEALTH!
Live / Allowed — Notice of allowance issued (as of 13 Jan 2026)
What this means for you
Approved and waiting on proof of use. It will register unless the applicant drops it, and its 24 Nov 2024 filing date already counts against anyone who files later.
Record
- Serial number
- 98870087
- Mark type
- Stylized text
- Filed
- 24 Nov 2024
- Published for opposition
- 18 Nov 2025
Goods and services
- Class 005 — Pharmaceuticals: Therapeutic pharmaceutical for the treatment of metabolic diseases; Therapeutic pharmaceutical for the treatment of infectious diseases; Therapeutic pharmaceutical for the treatment of cancer; Therapeutic pharmaceutical for the treatment of autoimmune diseases
Owner
- Samir K Lakhashe, San Antonio, TX, US
- Samir K Lakhashe, San Antonio, TX, US
Prosecution history
- 13 Jan 2026 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 18 Nov 2025 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 18 Nov 2025 — PUBLISHED FOR OPPOSITION
- 12 Nov 2025 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 20 Oct 2025 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 19 Oct 2025 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 19 Oct 2025 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 19 Oct 2025 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 01 Aug 2025 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 01 Aug 2025 — NON-FINAL ACTION E-MAILED
- 01 Aug 2025 — NON-FINAL ACTION WRITTEN
- 24 Jul 2025 — ASSIGNED TO EXAMINER
- 12 May 2025 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
- 24 Nov 2024 — APPLICATION FILING RECEIPT MAILED
- 24 Nov 2024 — NEW APPLICATION ENTERED